• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢氯噻嗪和吲哚美辛治疗对肾性尿崩症肾功能的影响。

Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.

作者信息

Jakobsson B, Berg U

机构信息

Department of Pediatrics, Huddinge University Hospital, Karolinska Institute, Sweden.

出版信息

Acta Paediatr. 1994 May;83(5):522-5. doi: 10.1111/j.1651-2227.1994.tb13072.x.

DOI:10.1111/j.1651-2227.1994.tb13072.x
PMID:8086732
Abstract

The purpose of this study was to investigate the effects of treatment with hydrochlorothiazide and hydrochlorothiazide and indomethacin combined on renal function in four boys, two with nephrogenic diabetes insipidus and two with partial nephrogenic diabetes insipidus using the clearances of inulin and para-aminohippuric acid under water diuresis and lithium clearance. Hydrochlorothiazide reduced urine flow and lithium clearance. These effects were further potentiated by addition of indomethacin. No consistent effects on renal plasma flow or glomerular filtration rate were found. It is concluded that treatment with hydrochlorothiazide alone and hydrochlorothiazide and indomethacin combined reduces urine flow in nephrogenic diabetes insipidus by increasing proximal tubular reabsorption of sodium.

摘要

本研究的目的是通过在水利尿和锂清除率情况下使用菊粉清除率和对氨基马尿酸清除率,来调查氢氯噻嗪以及氢氯噻嗪与吲哚美辛联合治疗对四名男孩肾功能的影响,其中两名患有肾性尿崩症,两名患有部分肾性尿崩症。氢氯噻嗪降低了尿流量和锂清除率。吲哚美辛的加入进一步增强了这些作用。未发现对肾血浆流量或肾小球滤过率有一致的影响。得出的结论是,单独使用氢氯噻嗪以及氢氯噻嗪与吲哚美辛联合治疗通过增加近端肾小管对钠的重吸收来降低肾性尿崩症患者的尿流量。

相似文献

1
Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.氢氯噻嗪和吲哚美辛治疗对肾性尿崩症肾功能的影响。
Acta Paediatr. 1994 May;83(5):522-5. doi: 10.1111/j.1651-2227.1994.tb13072.x.
2
Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
Clin Sci (Lond). 1984 Jun;66(6):709-15. doi: 10.1042/cs0660709.
3
Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
Pediatr Nephrol. 1987 Jul;1(3):485-90. doi: 10.1007/BF00849258.
4
Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.氨氯地平-氢氯噻嗪与吲哚美辛-氢氯噻嗪治疗肾性尿崩症的对比研究
J Pediatr. 1990 Sep;117(3):499-502. doi: 10.1016/s0022-3476(05)81106-0.
5
The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
Acta Paediatr Scand. 1983 Sep;72(5):717-20. doi: 10.1111/j.1651-2227.1983.tb09800.x.
6
A comparison of micropuncture and lithium clearance methods in the assessment of renal tubular function in rats with diabetes insipidus.在尿崩症大鼠肾小管功能评估中微穿刺法与锂清除率法的比较
Pflugers Arch. 1983 Dec;399(4):266-70. doi: 10.1007/BF00652750.
7
The role of sodium depletion in hydrochlorothiazide-induced antidiuresis in Brattleboro rats with diabetes insipidus.钠耗竭在去垂体尿崩症Brattleboro大鼠中氢氯噻嗪诱导的抗利尿作用中的作用。
Clin Sci Mol Med. 1978 Mar;54(3):209-15. doi: 10.1042/cs0540209.
8
Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.氢氯噻嗪-阿米洛利治疗先天性肾性尿崩症
Am J Nephrol. 1985;5(1):9-13. doi: 10.1159/000166896.
9
Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.
Acta Endocrinol (Copenh). 1984 Jul;106(3):311-6. doi: 10.1530/acta.0.1060311.
10
Mechanism of action of indomethacin in tubular defects.
Pediatrics. 1985 Mar;75(3):501-7.

引用本文的文献

1
Paradoxical Anti-diuretic Effects of Thiazide and Thiazide-Like Diuretics in Diabetes Insipidus: A Systematic Review.噻嗪类及噻嗪样利尿剂在尿崩症中的反常抗利尿作用:一项系统评价
Cureus. 2025 Apr 14;17(4):e82247. doi: 10.7759/cureus.82247. eCollection 2025 Apr.
2
Construction of arginine vasopressin receptor 2-deficient rats by the rGONAD method.通过rGONAD方法构建精氨酸加压素受体2缺陷型大鼠。
Clin Exp Nephrol. 2025 Mar 18. doi: 10.1007/s10157-025-02652-5.
3
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).
先天性肾性尿崩症(精氨酸加压素抵抗)诊断与管理的国际专家共识声明
Nat Rev Nephrol. 2025 Feb;21(2):83-96. doi: 10.1038/s41581-024-00897-z. Epub 2024 Oct 22.
4
Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study.先天性肾性尿崩症患儿的诊断、治疗及预后:一项儿科肾脏病研究联盟的研究
Front Pediatr. 2020 Jan 21;7:550. doi: 10.3389/fped.2019.00550. eCollection 2019.
5
Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.基于日本全国性调查的肾性尿崩症临床概述
Yonago Acta Med. 2014 Jun;57(2):85-91. Epub 2014 Jul 30.
6
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.肾源性尿崩症:对分子背景的基本认识及治疗的潜在疗法。
Endocr Rev. 2013 Apr;34(2):278-301. doi: 10.1210/er.2012-1044. Epub 2013 Jan 29.
7
Familial forms of diabetes insipidus: clinical and molecular characteristics.家族性尿崩症:临床与分子特征。
Nat Rev Endocrinol. 2011 Jul 5;7(12):701-14. doi: 10.1038/nrendo.2011.100.
8
Nephrogenic diabetes insipidus: treat with caution.肾性尿崩症:谨慎治疗。
Pediatr Nephrol. 2009 Sep;24(9):1761-3. doi: 10.1007/s00467-009-1187-9. Epub 2009 Apr 17.
9
Diuretics in pediatrics : current knowledge and future prospects.儿科利尿剂:当前认知与未来展望
Paediatr Drugs. 2006;8(4):245-64. doi: 10.2165/00148581-200608040-00004.
10
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.氢氯噻嗪与环氧化酶-2抑制剂治疗先天性肾性尿崩症
Pediatr Nephrol. 2003 Oct;18(10):1073-6. doi: 10.1007/s00467-003-1195-0. Epub 2003 Jul 18.